Last reviewed · How we verify
NCT03126409
No-Touch Versus Conventional Saphenous Vein Harvesting Technique
NA trial testing No-Touch vein harvesting technique in Coronary Artery Disease in 2,655 participants. Participants enrolled and being followed up; not accepting new ones.
30 December 2029
Quick facts
| Lead sponsor | China National Center for Cardiovascular Diseases |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 2,655 |
| Start date | 14 May 2017 |
| Primary completion | 30 December 2029 |
| Estimated completion | 30 December 2029 |
| Sites | 1 location across China |
Drugs / interventions tested
- No-Touch vein harvesting technique
- Conventional vein harvesting
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
China National Center for Cardiovascular Diseases — full company profile →
Who can join
18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the short-term patency of vein graft harvested by the No-Touch technique compared to that by the conventional approach in patients undergoing isolated on-pump/off-pump coronary artery bypass graft (CABG) surgery. a total of at least 2000 patients undergoing isolated on-pump/off-pump CABG will be consecutively recruited from 7 hospitals across China and randomly assigned to receive No-Touch saphenous vein harvesting or conventional approach. All participants will be invited for clinical follow-up and 64-slice multislice computed tomography angiography (MSCTA) analysis at 3 months post-operatively.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-Centre randomized control trial, NCT01047449).
Deb S, Singh SK, de Souza D, Chu MWA, et al · · 2019 · cited 86× · PMID 31046806 · DOI 10.1186/s13019-019-0887-x -
No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial.
Tian M, Wang X, Sun H, Feng W, et al · · 2021 · cited 80× · PMID 34510911 · DOI 10.1161/circulationaha.121.055525 -
Twenty-Five Years of No-Touch Saphenous Vein Harvesting for Coronary Artery Bypass Grafting: Structural Observations and Impact on Graft Performance.
Samano N, Souza D, Pinheiro BB, Kopjar T, et al · · 2020 · cited 26× · PMID 32270965 · DOI 10.21470/1678-9741-2019-0238 -
The evolving evidence base for coronary artery bypass grafting and arterial grafting in 2021: How to improve vein graft patency.
Vervoort D, Malik A, Fremes SE. · · 2021 · cited 13× · PMID 34977712 · DOI 10.1016/j.xjtc.2021.09.038 -
Stable Hemodynamics within "No-Touch" Saphenous Vein Graft.
Jiang Q, Yang Y, Sun H, Tang Y, et al · · 2020 · cited 11× · PMID 31611499 · DOI 10.5761/atcs.oa.19-00156 -
No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.
Tian M, Wang X, Feng W, Wang H, et al · · 2025 · cited 6× · PMID 40306935 · DOI 10.1136/bmj-2024-082883 -
Graft patency of no-touch versus conventionally harvested saphenous vein conduits in coronary artery bypass grafting: A frequentist and Bayesian meta-analysis of randomized trials.
Deng MX, Li Z, Vervoort D, Evan RN, et al · · 2025 · PMID 40309673 · DOI 10.1016/j.xjon.2025.02.007
Verify or expand the search:
- PubMed search for NCT03126409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other China National Center for Cardiovascular Diseases trials
Trials by the same sponsor.
- NCT07514988 — Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment · NA · not yet recruiting
- NCT07476456 — Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death · not yet recruiting
- NCT07302659 — Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG · NA · recruiting
- NCT07482683 — Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach · not yet recruiting
- NCT06787430 — Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03126409 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China National Center for Cardiovascular Diseases
- Last refreshed: 4 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03126409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing